Emcure Pharmaceuticals Ltd.
EMCURE
Classificação em ações
#4336
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Preço da ação
$18.87
Valor de mercado
$3.58B
Variação (1 dia)
-2.83%
Variação (1 ano)
19.28%
País
IN
Negociar Emcure Pharmaceuticals Ltd. (EMCURE)
Categoria
Healthcare
EPS de Emcure Pharmaceuticals Ltd. (EMCURE)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Emcure Pharmaceuticals Ltd., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da Emcure Pharmaceuticals Ltd. de 2025 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2025 | $0.01 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
